Logging Asthma Over the Long Haul: Making the Run-Up to an Attack Visible

Lead

When an attack arrives, looking back almost always reveals that the signs were there. A different cough pattern the day before. The weather that week. A stretch of days when sports-day practice ran long. Without records, those patterns stay vague, half-remembered, easy to doubt.

Pediatric asthma is one of the most common chronic conditions in Japan, and it follows a child across years of their life [1,2]. Clinical guidelines provide a solid framework for treatment, but day-to-day management depends heavily on caregiver observation — and what caregivers observe can substantially sharpen the decisions made in the clinic. Making the run-up to an attack visible does more than improve communication with the medical team; it gives parents a way to convert anxiety into something they can actually work with.

Epidemiology and long-term trajectory

The documented the global scope of pediatric asthma in a cross-sectional study of more than 460,000 children aged 13–14 across 56 countries, finding up to a 20-to-60-fold difference in the prevalence of asthma symptoms between countries [3]. In Japan specifically, the prevalence of childhood asthma among boys rose from 3.8% in 1982 to 8.1% in 2002, then declined in surveys conducted in 2012 and 2022 [1]. A 2025 review of national Japanese survey data across four decades confirms that, despite the downward trend, pediatric asthma remains one of the most prevalent chronic conditions in the 0–6 age group [5].

Asthma follows a pattern of remission and relapse. Symptoms that appear to ease during the school years can flare again in adolescence. The 2024 Global Initiative for Asthma (GINA) guidelines list reduced symptom frequency and severity, good lung function, and improved airway hyper-responsiveness as predictors of remission in childhood asthma; persistent risk factors include , parental history of asthma or allergy, and early onset [2]. The reason a long view is necessary is that "controlling the current attack" is not, by itself, enough. A child who appears well-controlled during one school year can deteriorate significantly the next, particularly around the transition from preschool to elementary school, when exposure to new viral environments increases and the social demands placed on the child change.

Recording environmental triggers to predict attacks

Attacks may seem to arrive without warning, but most are preceded by environmental triggers. Dust mites, mold, pollen, tobacco smoke, air pollution, respiratory infections, exercise, temperature changes, and stress are among the most commonly cited [2]. The challenge is that each child responds to a different set of triggers at different thresholds. Guidelines can enumerate common cautions, but which triggers matter most for this child only becomes visible through individual, long-term records.

This is not a hypothetical point. A child who consistently worsens on rainy days in October, or whose attacks cluster in the week after a cold, or who shows deterioration two days after visiting a particular relative's home — that pattern cannot be identified without a log. The connection between exposure and symptom onset in asthma is often delayed by 12–48 hours, which makes memory an unreliable tool and a dated record an essential one.

measurement is a useful tool for school-age children: it quantifies the degree of airflow limitation numerically. Deterioration usually tracks a drop in PEFR to below 80% of the child's personal best [2]. The GINA traffic-light system builds on this: readings above 80% of personal best (green zone) indicate good control; between 60–80% (yellow zone) indicate caution and require step-up; below 60% (red zone) require urgent medical contact [2]. Logging daily PEFR readings with dates — and then cross-referencing against "what happened the day before" — progressively improves the accuracy of trigger identification.

The written asthma action plan and the role of records

A Cochrane review of asthma self-management education (Gibson et al., 2003) analyzed the combination of information delivery, self-monitoring, regular clinician review, and a documented written action plan, finding a relative 42% reduction in hospitalizations (RR 0.58) and a 22% reduction in emergency visits (RR 0.78) [4]. These are not small numbers, and the effect is attributed to the combination — no single element alone produced the magnitude of benefit that the complete package did. The written asthma action plan (WAAP) in particular functions not merely as a reference document but as a shared language between caregivers and the medical team: it defines, in advance, what the parent should do when the yellow zone is reached rather than making that decision under stress at 2 a.m.

Japan's national clinical guidelines for pediatric asthma — the JPGL 2020 (Pediatric Bronchial Asthma Treatment and Management Guidelines) — base step adjustments on assessed control status and emphasize the importance of sustained treatment from infancy alongside environmental management [1]. Control status is assessed at each clinic visit using criteria such as frequency, nocturnal symptom frequency, and activity limitation. The difference in clinical precision between a parent who can report "three wheezing episodes in the past month, all at night, each after outdoor play" and one who says "it felt like there were more than usual" is not trivial. The log is the translator that carries caregiver observation into medical decision-making.

What to record — a practical guide

Four categories of information are most useful for tracking respiratory symptoms.

1. Presence and intensity of symptoms. Cough, wheezing, and chest tightness, recorded on a rough scale — none / mild / moderate / severe. The goal is not precision for its own sake; it is to make visible, week by week, what happened in the days before a bad spell.

2. Trigger candidates. Weather (temperature and humidity), locations visited, presence of a cold, activity level, foods eaten (where food allergy is a factor). A brief note is enough at first.

3. Medication use. Record days when a rescue bronchodilator is used, and note the time of day if possible. Increasing frequency is typically an early sign that control is slipping [2]. A parent who can show the doctor that rescue use went from once a week to three times a week over four weeks has provided actionable information; a parent who says "we've been using it more" has not.

4. Peak flow readings (when measurement is feasible). Twice daily — morning and bedtime — is ideal, but one consistent measurement per day is more valuable than inconsistent twice-daily ones. For younger children who cannot yet cooperate with peak flow measurement, caregiver assessment of symptom severity using the four-point scale above carries similar functional value.

Using an app like Memori to layer symptom notes and health records over a shared timeline can surface patterns that are hard to see day by day: "this season always brings a downturn," or "attacks cluster in the second half of the week at daycare," or "the rescue inhaler use jumped right when pollen counts peaked." Printing a month's worth of that timeline to bring to a clinic appointment can qualitatively change the conversation with the physician. It changes the physician's role from detective to partner.

Summary

Pediatric asthma is a condition that can be well controlled with appropriate long-term management [2]. But management accuracy is difficult to improve without the foundation of systematic daily observation. Making the run-up to an attack visible, sharing a written action plan with the medical team, and maintaining the habit of bringing records to appointments are, according to the evidence, the core of effective self-management [4].

The goal of keeping records is not to produce a perfect data set. It is to maintain a state in which you can tell the physician: "Here is what changed since last month."

References

Japanese Society of Pediatric Allergy and Clinical Immunology. Executive summary of the JPGL 2020: Guidelines for pediatric bronchial asthma treatment and management. Allergol Int. 2022;71(4):460–470. PMID: 36085113.
Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2024. https://ginasthma.org/
ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998;351(9111):1225–1232. PMID: 9643741.
Gibson PG, Powell H, Wilson A, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003;(1):CD001117. doi:10.1002/14651858.CD001117. PMID: 12535399.
Ishizuka T, Matsuoka K, Oka A, et al. Surveys on the prevalence of pediatric asthma in Japan. World Allergy Organ J. 2025. doi:10.1016/j.waojou.2025.100987.